Delcath Systems, Inc. , an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced that the U.S. Food and Drug Administration (FDA) has ...

The global knotless tissue control devices market is experiencing dynamic growth, with recent market research forecasting a robust Compound Annual Growth Rate (CAGR) of 3.4% from 2022 to 2032.

At the Radiological Society of North America’s (RSNA) 2024 Annual Meeting taking place from Dec. 1-4 in Chicago, GE HealthCare (Nasdaq: GEHC) will exhibit more than 40 innovations, including several ...